Epstein-Barr virus and disease activity in multiple sclerosis.

Area of Science:

• Neuroimmunology
• Virology

Background:

• Epstein-Barr virus (EBV) is a common human herpesvirus with a complex relationship to multiple sclerosis (MS).
• Previous research suggests a potential link between EBV infection and MS pathogenesis, but the role of active EBV replication in MS disease activity remains unclear.

Purpose of the Study:

• To investigate the association between plasma levels of anti-EBV antibodies and EBV DNA with clinical exacerbations and MRI-detected brain activity in relapsing-remitting MS (RRMS).

Main Methods:

• A prospective study followed 73 RRMS patients for an average of 1.7 years.
• Plasma EBV antibodies (IgG, IgM) and EBV DNA were measured using ELISA and PCR, respectively.
• Neurological examinations and gadolinium-enhanced MRI scans were performed to assess disease activity.

Main Results:

• All MS patients exhibited IgG antibodies to EBV, with 48% showing antibodies indicating active replication (anti-EBV early antigen, EA), compared to 25% of healthy controls.
• No significant difference in EA antibody levels or EBV DNA was found between stable disease and exacerbation phases.
• While clinical disease activity did not differ, patients with anti-EA antibodies showed increased MRI-detected inflammatory lesions.

Conclusions:

• No evidence supports increased clinical disease activity in MS patients with serological signs of EBV reactivation.
• The association between chronic EBV reactivation and increased inflammatory activity on MRI in MS warrants further investigation in larger cohorts.